Lipella Pharmaceuticals Net Tangible Assets

Lipella Pharmaceuticals (LIPO) currently reports a net tangible assets of $1.5B as of September 2025. That compares with $1.5B in the prior-year period — up 2.0% year over year. Use the charts on this page to explore Lipella Pharmaceuticals's net tangible assets history and peer comparisons.

Lipella Pharmaceuticals's net tangible assets increased from $1.5B to $1.5B — a 2.0% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lipella Pharmaceuticals reported $1.5B in net tangible assets as of September 2025. That compares with $1.5B in the prior-year period — up 2.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $1.5B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lipella Pharmaceuticals, and consider following LIPO for alerts when major investors trade the stock.